Tom A. Van Den Ende
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Targeting the gut microbiota as a treatment for obesity and cancer cachexia.
Journal: Expert opinion on emerging drugs
Published: March 21, 2026
Response prediction after neoadjuvant chemoradiotherapy in esophageal cancer using FDG-PET and multiparametric MRI: A prospective multicenter study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: March 20, 2026
Response prediction after neoadjuvant chemoradiotherapy in esophageal cancer using FDG-PET and multiparametric MRI: A prospective multicenter study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: March 20, 2026
Second-line oxaliplatin reintroduction or paclitaxel-ramucirumab in metastatic gastroesophageal cancer: a population-based study.
Journal: Therapeutic advances in medical oncology
Published: October 08, 2025
Fecal, duodenal, and tumor microbiota composition of esophageal carcinoma patients, a longitudinal prospective cohort.
Journal: Journal of the National Cancer Institute
Published: May 02, 2024
Nanopore-based consensus sequencing enables accurate multimodal tumor cell-free DNA profiling.
Journal: Genome research
Published: February 22, 2024
High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy.
Journal: Journal for immunotherapy of cancer
Published: November 06, 2023
Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition.
Journal: Oncoimmunology
Published: July 20, 2023
The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma.
Journal: Communications medicine
Published: May 01, 2023
Genome-wide and panel-based cell-free DNA characterization of patients with resectable esophageal adenocarcinoma.
Journal: The Journal of pathology
Published: March 13, 2023
Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis.
Journal: Cell reports. Medicine
Published: February 03, 2023
Predictive value of radiological response, pathological response and relapse-free survival for overall survival in neoadjuvant immunotherapy trials: pooled analysis of 29 clinical trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 03, 2022
Last Updated: 09/26/2026